Literature DB >> 24486472

Complications, outcomes, and need for fusion after minimally invasive posterior cervical foraminotomy and microdiscectomy.

Branko Skovrlj1, Yakov Gologorsky1, Raqeeb Haque2, Richard G Fessler2, Sheeraz A Qureshi3.   

Abstract

BACKGROUND CONTEXT: Posterior cervical foraminotomy (PCF) with or without microdiscectomy (posterior cervical discectomy [PCD]) is a frequently used surgical technique for cervical radiculopathy secondary to foraminal stenosis or a laterally located herniated disc. Currently, these procedures are being performed with increasing frequency using advanced minimally invasive techniques. Although the safety and efficacy of minimally invasive PCF/PCD (MI-PCF/PCD) have been established, reports on long-term outcome and need for secondary surgical intervention at the index or adjacent level are lacking.
PURPOSE: To determine the rates of complications, long-term outcomes, and need for secondary surgical intervention at the index or adjacent level after MI-PCF and microdiscectomy. STUDY
DESIGN: Retrospective analysis of a prospective cohort. PATIENT SAMPLE: Seventy patients treated with MI-PCF and/or MI-PCD for cervical radiculopathy. OUTCOME MEASURES: Visual Analog Scale for neck/arm (VASN/A) pain and Neck Disability Index (NDI).
METHODS: Ninety-seven patients underwent MI-PCF with or without MI-PCD between 2002 and 2011. Adequate prospective follow-up was available for 70 patients (95 cervical levels). The primary outcome assessed was need for secondary surgical intervention at the index or adjacent level. The secondary outcomes assessed included complications and improvements in NDI and VASN/A scores. All complications were reviewed. Mixed-model analyses of variance with random subject effects and autoregressive first-order correlation structures were used to test for differences among NDI, VASA, and VASN measurements made over time while accounting for the correlation among repeated observations within a patient. All statistical hypothesis tests were conducted at the 5% level of significance.
RESULTS: Patients were followed for a mean of 32.1 months. Of 70 patients operated, there were 3 (4.3%) complications (1 cerebrospinal fluid leak, 1 postoperative wound hematoma, and 1 radiculitis), none of which required a secondary operative intervention. Five patients required an anterior cervical discectomy and fusion (eight total levels fused) on average 44.4 months after the index surgery. Of those, five (5.3%) were at the index level and three (2.1%) were at adjacent levels. Neck Disability Index scores improved significantly (p<.0001) immediately postoperatively and continued to decrease gradually with time. Visual Analog Scale for neck/arm scores improved significantly (p<.0001) from baseline immediately postoperatively but tended to plateau with time.
CONCLUSIONS: Minimally invasive PCF with or without MI-PCD is an excellent alternative for cervical radiculopathy secondary to foraminal stenosis or a laterally located herniated disc. There is a low rate (1.1% per index level per year) of future index site fusion and a very low rate (0.9% per adjacent level per year) of adjacent-level disease requiring surgery.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjacent-level disease; Anterior cervical fusion; Complications; Microdiscectomy; Outcome scores; Posterior cervical foraminotomy

Mesh:

Year:  2014        PMID: 24486472     DOI: 10.1016/j.spinee.2014.01.048

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  22 in total

1.  Minimally invasive cervical foraminotomy and diskectomy for laterally located soft disk herniation.

Authors:  Chi Heon Kim; Kyoung-Tae Kim; Chun Kee Chung; Sung Bae Park; Seung Heon Yang; Sung Mi Kim; Joo-Kyung Sung
Journal:  Eur Spine J       Date:  2015-08-23       Impact factor: 3.134

2.  Posterior endoscopic cervical foramiotomy and discectomy: clinical and radiological computer tomography evaluation on the bony effect of decompression with 2 years follow-up.

Authors:  Hyeun Sung Kim; Pang Hung Wu; Yeon Jin Lee; Dae Hwan Kim; Jun Hyung Lee; Kyung-Hoon Yang; Harshavardhan Dilip Raorane; Il-Tae Jang
Journal:  Eur Spine J       Date:  2020-10-19       Impact factor: 3.134

Review 3.  Minimally invasive spine surgery for degenerative spine disease and deformity correction: a literature review.

Authors:  Marios G Lykissas; Dionysios Giannoulis
Journal:  Ann Transl Med       Date:  2018-03

4.  Clinical and radiological outcomes of two-level endoscopic posterior cervical foraminotomy.

Authors:  Myung Soo Youn; Myeong Hwan Shon; Yoon Jae Seong; Jong Ki Shin; Tae Sik Goh; Jung Sub Lee
Journal:  Eur Spine J       Date:  2017-03-23       Impact factor: 3.134

Review 5.  Minimally invasive posterior cervical foraminotomy for treatment of radiculopathy : An effective, time-tested, and cost-efficient motion-preservation technique.

Authors:  L Papavero; R Kothe
Journal:  Oper Orthop Traumatol       Date:  2017-09-19       Impact factor: 1.154

Review 6.  Minimally invasive posterior cervical foraminotomy versus anterior cervical discectomy and fusion for cervical radiculopathy: a meta-analysis.

Authors:  Tao Zou; Ping-Chuan Wang; Hao Chen; Xin-Min Feng; Hui-Hui Sun
Journal:  Neurosurg Rev       Date:  2022-10-18       Impact factor: 2.800

Review 7.  Cervical radiculopathy.

Authors:  Sravisht Iyer; Han Jo Kim
Journal:  Curr Rev Musculoskelet Med       Date:  2016-09

Review 8.  Microsurgery or open cervical foraminotomy for cervical radiculopathy? A systematic review.

Authors:  Zhaojun Song; Zhi Zhang; Jie Hao; Jieliang Shen; Nian Zhou; Shengxi Xu; Weidong Ni; Zhenming Hu
Journal:  Int Orthop       Date:  2016-04-25       Impact factor: 3.075

9.  Minimally Invasive Cervical Foraminotomy.

Authors:  Steven J McAnany; Sheeraz A Qureshi
Journal:  JBJS Essent Surg Tech       Date:  2016-06-08

10.  Long-term clinical and radiologic outcomes of minimally invasive posterior cervical foraminotomy.

Authors:  Young-Joon Kwon
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.